Cargando…
Infliximab dose adjustment can improve the clinical and radiographic outcomes of rheumatoid arthritis patients: REVIVE study results
PURPOSE: We evaluated the clinical responses and radiographic outcomes of 90 patients with rheumatoid arthritis (RA) undergoing continuous or dose-adjusted infliximab treatment over 104 weeks. PATIENTS AND METHODS: Patients received 3 mg/kg infliximab continuously (the contin group; n=50), or the do...
Autores principales: | Nozaki, Yuji, Nagare, Yasuaki, Ashida, Chisato, Tomita, Daisuke, Okada, Akinori, Inoue, Asuka, Kinoshita, Koji, Funauchi, Masanori, Matsumura, Itaru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267494/ https://www.ncbi.nlm.nih.gov/pubmed/30568425 http://dx.doi.org/10.2147/BTT.S187998 |
Ejemplares similares
-
The Effectiveness and Retention Rate of Iguratimod in Japanese Rheumatoid Arthritis Patients with/without Methotrexate in Daily Medical Care
por: Inoue, Asuka, et al.
Publicado: (2020) -
Foxp3-Positive Regulatory T Cells Contribute to Antifibrotic Effects in Renal Fibrosis via an Interleukin-18 Receptor Signaling Pathway
por: Hirooka, Yasuaki, et al.
Publicado: (2020) -
Real-World Methotrexate Dose on Clinical Effectiveness and Structural Damage of Certolizumab Pegol With Rheumatoid Arthritis
por: Nozaki, Yuji, et al.
Publicado: (2021) -
Antiretroviral Therapy Improves Acquired Immunodeficiency Syndrome with Systemic Lupus Erythematosus
por: Okada, Akinori, et al.
Publicado: (2021) -
Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset Still’s Disease With/Without Macrophage Activation Syndrome From Other Secondary Hemophagocytic Lymphohistiocytosis in Adults
por: Shiga, Toshihiko, et al.
Publicado: (2021)